HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lucie Sharpsten Selected Research
Lucie Sharpsten Research Topics
Disease
2
Heart Failure
01/2021 - 11/2020
2
Chronic Obstructive Pulmonary Disease (COPD)
01/2019 - 01/2018
1
Weight Loss (Weight Reduction)
02/2024
1
Systolic Heart Failure
01/2021
1
Infections
11/2019
1
Asthma (Bronchial Asthma)
01/2019
1
Macular Degeneration (Age-Related Maculopathy)
03/2015
1
Retinitis
01/2015
1
Papilledema
01/2015
1
Ocular Hypertension (Glaucoma, Suspect)
07/2014
1
Glaucoma
07/2014
Drug/Important Bio-Agent (IBA)
2
omecamtiv mecarbil
IBA
01/2021 - 11/2020
2
Cardiac Myosins
IBA
01/2021 - 11/2020
2
vilanterol
IBA
01/2019 - 01/2018
2
GSK573719
IBA
01/2019 - 01/2018
2
Retinaldehyde (Retinal)
IBA
01/2015 - 07/2014
1
Peptides (Polypeptides)
IBA
02/2024
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
02/2024
1
sacubitril and valsartan sodium hydrate drug combination
IBA
11/2020
1
Natriuretic Peptides
IBA
11/2020
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
11/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2019
1
Fluticasone-Salmeterol Drug Combination (Advair)
FDA Link
01/2019
1
Muscarinic Antagonists
IBA
01/2019
1
aflibercept
IBA
03/2015
Therapy/Procedure
5
Therapeutics
01/2021 - 01/2018
1
Nebulizers and Vaporizers (Inhaler)
01/2019